Takara Bio Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,743

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 9

Takara Bio General Information

Description

Developer of biotechnology products designed to support life science research and drug discovery. The company offers restriction enzymes, pcr reagents, scientific instruments, cdmo services, cell culture media, and gene therapy candidates, enabling pharmaceutical companies and academic institutions to advance regenerative medicine and genetic analysis.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4-38, Noji-Higashi 7-chome
  • Kusatsu City, Shiga Prefecture 525-0058
  • Japan
Primary Industry
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 4-38, Noji-Higashi 7-chome
  • Kusatsu City, Shiga Prefecture 525-0058
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Takara Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Takara Bio‘s full profile, request access.

Request a free trial

Takara Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology products designed to support life science research and drug discovery. The company offers res
Biotechnology
Kusatsu City, Japan
1,743 As of 2026

Irvine, CA
 

Shirley, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Takara Bio Competitors (70)

One of Takara Bio’s 70 competitors is GeneTex, a Formerly VC-backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneTex Formerly VC-backed Irvine, CA
CD Genomics Corporation Shirley, NY
Novogene Formerly PE-Backed Beijing, China
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
You’re viewing 5 of 70 competitors. Get the full list »

Takara Bio Patents

Takara Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026141547-A1 Optimization of 3'ltr upstream sequence in lentiviral vector Pending 26-Dec-2024
WO-2026089040-A1 Rna polymerase mutant Pending 25-Oct-2024
WO-2025205770-A1 Recombinant plasmid containing stuffer dna Pending 26-Mar-2024
WO-2025164636-A1 Rna-capping enzyme derived from faustovirus s17 Pending 30-Jan-2024
EP-4825963-A1 Rna polymerase variant and rna synthesis Pending 12-Dec-2023 C12N9/1247
To view Takara Bio’s complete patent history, request access »

Takara Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Takara Bio Investments & Acquisitions (9)

Takara Bio’s most recent deal was a Merger/Acquisition with ViSpot. The deal was made on 01-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ViSpot 01-May-2025 Merger/Acquisition Laboratory Services (Healthcare)
StemCells (Stem Cell-related Research Products) 11-Nov-2014 Corporate Asset Purchase Buildings and Property
Cellectis bioresearch (Sweden) 04-Sep-2014 Merger/Acquisition Biotechnology
DSS Takara Bio India 01-Jan-2011 Joint Venture Discovery Tools (Healthcare)
Nanosphere 26-Apr-2006 Later Stage VC Diagnostic Equipment
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Takara Bio Exits (4)

Takara Bio’s most recent exit was on 26-Apr-2006 from Nanosphere. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Nanosphere 26-Apr-2006 Completed
  • 4 buyers
Helixmith 23-Feb-2005 Completed
  • 10 buyers
Nanosphere 26-Nov-2002 Completed
  • 3 buyers
Helixmith 01-Mar-2000 Corporate Completed
To view Takara Bio’s complete exits history, request access »

Takara Bio Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Cellectis bioresearch (Sweden) Gothenburg, Sweden 2001
Takara Bio Europe Saint-Germain-En-Laye, France 1995
Takara Bio (GMP Cell Processing Contract Business) Kusatsu, Japan

Takara Bio FAQs

  • When was Takara Bio founded?

    Takara Bio was founded in 2002.

  • Where is Takara Bio headquartered?

    Takara Bio is headquartered in Kusatsu City, Japan.

  • What is the size of Takara Bio?

    Takara Bio has 1,743 total employees.

  • What industry is Takara Bio in?

    Takara Bio’s primary industry is Biotechnology.

  • Is Takara Bio a private or public company?

    Takara Bio is a Private company.

  • What is the current valuation of Takara Bio?

    The current valuation of Takara Bio is .

  • What is Takara Bio’s current revenue?

    The current revenue for Takara Bio is .

  • How much funding has Takara Bio raised over time?

    Takara Bio has raised $77M.

  • Who are Takara Bio’s competitors?

    GeneTex, CD Genomics, Novogene, Genetix Biotherapeutics, and Abcam are some of the 70 competitors of Takara Bio.

  • When was Takara Bio acquired?

    Takara Bio was acquired on 10-Apr-2026.

  • Who acquired Takara Bio?

    Takara Bio was acquired by Takara Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process